- Anti-CD25 (PC61) (BE0012): Regulatory T cell studies
- Anti-CD4 (GK1.5) (BE0003-1): T cell characterization
- Anti-CTLA-4 (9H10 (BE0131), BN13 (BE0237), or Ipilimumab biosimilar (SIM0004): Immune checkpoint pathways
- Anti-PD-1 (RMP1-14 (BP0146), 29F.1A12 (BE0273), J43 (BE0033-2)): Checkpoint and tolerance research
Celebrating a Milestone in Immunology Research
Tags
- Category: Articles
Congratulations to Shimon Sakaguchi, Mary Brunkow, and Fred Ramsdell, the 2025 Nobel Laureates in Physiology or Medicine, for discoveries that revealed how the immune system maintains balance. Their work uncovered regulatory T cells (Tregs) and the FOXP3 gene, showing that immune tolerance is an active, gene-driven process essential for preventing autoimmunity and shaping today’s immunotherapy strategies.
Bio X Cell’s in vivo functional grade antibodies are engineered to support foundational discoveries in immune tolerance, Tregs, and FOXP3 biology. Key antibodies cited the field of immune tolerance include:
Back to News
Meet Our Leaders
Learn more about the team behind the gold standard in vivo antibodies.
Discover Bio X Cell
Learn more about our proven expertise and comprehensive antibody solutions.
See Our Impact
Discover the Bio X Cell Fund’s mission to improve the health of our community
Explore Our Latest
See our latest articles and whitepapers for scientific insights and ideas
Don’t see what you need?
Consult With Bio X Cell to Enable Your Next Breakthrough Discovery
Whether you need antibody customization or high-volume production, Bio X Cell is committed to advancing your therapeutic innovations.
Contact Us